Linaptin M 2.5 mg+850 mg (Tablet)
Unit Price: ৳ 14.00 (5 x 4: ৳ 280.00)
Strip Price: ৳ 56.00
Medicine Details
| Category | Details |
|---|---|
| Generic | Linagliptin metformin hydrochloride |
| Company | General pharmaceuticals ltd |
| Also available as |
Indications
- Adjunct to diet and exercise
- Improves glycemic control
- Type 2 diabetes mellitus
Pharmacology
- Inhibitor of DPP-4 enzyme
- Increases active incretin hormone concentrations
- Stimulates insulin release
- Decreases glucagon secretion
- Biguanide type oral antihyperglycemic drug
- Lowers plasma glucose
- Improves insulin sensitivity
- Decreases hepatic glucose production
Dosage & Administration
- Maximum recommended dose: 2.5 mg Linagliptin and 1000 mg Metformin Hydrochloride
- Gradual dose escalation
- Immediate release tablet
- Extended release tablet
- Individualized dosage based on effectiveness and tolerability
Interaction
- Cationic Drugs
- Carbonic Anhydrase Inhibitors
- Inducers of P-glycoprotein and CYP3A4 Enzymes
- Drugs Affecting Glycemic Control
Contraindications
- Renal impairment
- Metabolic acidosis
- Hypersensitivity to components
Side Effects
- Nasopharyngitis
- Diarrhea
- Hypoglycemia
Pregnancy & Lactation
- Use during pregnancy if clearly needed
- Caution during lactation
Precautions & Warnings
- Lactic acidosis
- Pancreatitis
- Radiologic studies precautions
- Monitoring Vitamin B12 levels
- Symptoms of lactic acidosis
- Alcohol consumption precautions
- Other medicines precautions
- Counseling
- Travel recommendations
- Emergency preparedness
- Hypoglycemia symptoms
- Treatment of low blood sugar symptoms
Overdose Effects
- Supportive measures for overdose
- Clinical monitoring
- Hemodialysis or peritoneal dialysis for Metformin overdose
- No dose-related clinical adverse drug reactions with Linagliptin overdose
Therapeutic Class
- Combination Oral hypoglycemic preparations
Storage Conditions
- Cool & dry place
- Protected from light & moisture
- Below 30°C
- Keep out of the reach of children